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Summary
 
Granzyme B (GraB) induces apoptosis in the presence of perforin. Perforin polymerizes in the
cell membrane to form a nonspecific ion pore, but it is not known where GraB acts to initiate
the events that ultimately lead to apoptosis. It has been hypothesized that GraB enters the target
cell through a perforin channel and then initiates apoptosis by cleaving and activating members
of the ICE/Ced-3 family of cell death proteases. To determine if GraB can enter the cell, we
treated YAC-1 or HeLa cells with FITC-labeled GraB and measured intracellular fluorescence
with a high sensitivity CCD camera and image analyzer. GraB was internalized and found dif-
fusely dispersed in the cell cytoplasm within 10 min. Uptake was inhibited at low temperature
(4
 
8
 
C) and by pretreatment with metabolic inhibitors, NaF and DNP, or cytochalasin B, a drug
that both blocks microfilament formation, and FITC-GraB remained on the cell membrane lo-
calized in patches. With the simultaneous addition of perforin and FITC-GraB, no significant
increase in cytoplasmic fluorescence was observed over that found in cells treated only with
FITC-GraB. However, FITC-GraB was now detected in the nucleus of apoptotic cells label-
ing apoptotic bodies and localized areas within and along the nuclear membrane. The ability of
GraB to enter cells in the absence of perforin was reexamined using anti-GraB antibody immu-
nogold staining of ultrathin cryosections of cells incubated with GraB. Within 15 min, gold
particles were detected both on the plasma membrane and in the cytoplasm of cells with some
gold staining adjacent to the nuclear envelope but not in the nucleus. Cells internalizing GraB
in the absence of perforin appeared morphologically normal by Hoechst staining and electron
microscopy. GraB directly microinjected into the cytoplasm of B16 melanoma cells induced
transient plasma membrane blebbing and nuclear coarsening but the cells did not become
frankly apoptotic unless perforin was added. We conclude that GraB can enter cells autono-
mously but that perforin initiates the apoptotic process and the entry of GraB into the nucleus.
 
C
 
TL and NK cells induce apoptosis through granule-
or Fas-dependent pathways (1–5). Initiation of apop-
tosis by granule exocytosis is the result of the action of two
types of molecules, the pore-forming protein perforin and
the lymphocyte-specific granule serine esterase granzyme B
(GraB)
 
1
 
, which together can reproduce all of the features of
CTL-induced apoptosis (6–8). In mice made deficient in
perforin or GraB as a result of a directed gene targeting,
CTL/NK cytotoxicity and apoptosis do not proceed nor-
mally (1–5, 9). The exact mechanism by which these mol-
ecules interact to produce apoptosis is not understood. Per-
forin polymerizes in the plasma membrane in the presence
of calcium and allows the nonspecific entry of ions (10–12).
At high doses of perforin the cell membrane is damaged as
measured by the loss of cytoplasmic proteins, however, per-
forin by itself does not induce apoptosis when incubated
with target cells of different types (6, 7). Similarly, purified
GraB and other granzymes induce apoptosis in the presence
of perforin, yet the protease has no effect when incubated
with a target cell alone (6, 7).
GraB cleaves proteins after aspartic acid (7, 13) and this
proteolytic specificity is shared with members of the cys-
teine protease interleukin-1
 
b
 
–converting enzyme (ICE)
family (14), which are homologues of the CED-3 cell
death gene of 
 
Caenorhabditus elegans
 
 (15). Recent work sug-
gests that GraB can proteolytically cleave and activate sev-
eral members of ICE family in vitro including CPP32 (16–
19), MCH3/ICE-LAP3 (18, 19), MCH4 (18), FLICE/
 
1
 
Abbreviations used in this paper:
 
 GraB, granzyme B; ICE, interleukin-1
 
b
 
–
converting enzyme; PARP, poly-ADP ribose polymerase.
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Mach1/MCH5 (20, 21), ICE-LAP6
 
 
 
(22), and ICH-3 (23).
There is also increasing evidence that ICE homologues are
required for GraB- and perforin-induced apoptosis. For ex-
ample, inhibition of ICE family protease activity using tet-
rapeptide inhibitors Ac-DEVD-CHO or Ac-YVAD-CHO,
which react with different ICE protease catalytic sites (24,
25), and overexpression of a dominant negative mutant of
ICE (25) suppress GraB apoptosis. Furthermore, fibroblasts
and B cells from mice deficient in ICE on the basis of di-
rected gene deletion (26) show high levels of resistance to
GraB-mediated apoptosis (25).
ICE is a cytoplasmic protease in monocytes, however,
the exact subcellular localization of this protease or other
members of the family is not known. Thus, to initiate apop-
tosis after its release by CTL, GraB would likely need to
cross the target cell plasma membrane. Currently, there is
no direct evidence that GraB penetrates the target cell at
any time during the induction of apoptosis. GraB can enter
isolated nuclei (27), although the functional significance is
unclear since GraB does not cause apoptotic morphological
changes to isolated nuclei in the absence of cytosol (24).
In this study, we report that GraB is able to rapidly enter
the cell cytoplasm via an energy-dependent mechanism in
the absence of perforin. Perforin does not significantly af-
fect GraB intracellular concentration, but it does initiate
apoptosis and GraB translocation to the nucleus. Thus, we
conclude that GraB has the capacity to autonomously enter
the cell cytoplasm where it remains inactive, and requires
some critical signal from perforin to initiate apoptosis and
nuclear translocation.
 
Materials and Methods
 
Reagents and Cells.
 
Rat and human GraB and rat perforin
were purified as described in earlier publications (6, 7, 16). YAC-1
or Rat-1 cells were cultured in RPMI 1640 supplemented with
10% FCS and penicillin-streptomycin, while B16 melanoma cells
were cultured in 
 
a
 
-MEM supplemented with 10% FCS, penicil-
lin-streptomycin and 2 mM l-glutamine. Hoechst 332385, cy-
tochalasin B, NaF, DNP, rhodamine-conjugated transferrin, digi-
tonin, and Triton X-100 were obtained from Sigma Chem. Co.
(St. Louis, MO). 
Monoclonal 2C5 anti-GraB antibody has been described pre-
viously (28). The mAb recognizes a 32-kD protein in cells trans-
fected with GraB cDNA but not H, A, or Met-ase and the same
32-kD protein in human peripheral blood lymphocyte and cyto-
toxic lymphocyte cell line YT. It also does not recognize gran-
zymes A, H, or Met-ase determined by reactivity with GST fu-
sion proteins. The antibody immunoprecipitates asp-ase but not
tryptase, Met-ase or chymase activities from LAK cells.
For fluorescenation, human GraB (60 
 
m
 
g/ml) was equilibrated
in 0.2 M NaCl/Na borate buffer, pH 9.2. FITC (1 mg/ml in the
same buffer) was then added for 2 h at ambient temperature. Un-
coupled FITC was removed by dialysis.
 
Apoptosis Assays.
 
Apoptosis was assayed as described in an
earlier publication (6). In experiments in which GraB was prein-
cubated with target cells, YAC-1 cells were first labeled with
 
125
 
IUdR for 90 min, washed, and then 2 
 
3
 
 10
 
4
 
 cells were incu-
bated with GraB at increasing concentrations in 80 
 
m
 
l of HBSS
with 2 mg/ml of BSA at 37
 
8
 
C. After an incubation of 15–60 min,
cells were washed two times with HBSS and then 5 
 
3
 
 10
 
3
 
 cells
were placed in a V-bottomed microtiter plate with perforin at the
concentrations indicated for an additional 2–4 h. Cells were ana-
lyzed as described previously. Experiments in which apoptosis was
analyzed by chromatin condensation with Hoechst dye used in
previously published methods (25).
 
Fluorescence Microscopy.
 
HeLa or YAC-1 cells were washed
twice in HBSS and then resuspended at 2.5 
 
3
 
 10
 
6
 
 cells/ml in
HBSS containing 10 mM Hepes, 2 mM CaCl
 
2,
 
 and 4 mg/ml
BSA, pH 7.2. Aliquots of 2 
 
3
 
 10
 
5
 
 cells in 80 
 
m
 
l were added to 80 
 
m
 
l
of FITC-GraB (final concentration 0.25–2 
 
m
 
g/ml), with or with-
out perforin diluted in buffer containing 140 mM NaCl, 10 mM
Hepes, 1 mM EGTA, pH 7.2. In some experiments cells were
preincubated for 15 min at room temperature with 100 
 
m
 
M
DNP and 1 mM NaF, or 2 
 
m
 
g/ml cytochalasin B, and then the
cells incubated with FITC-GraB. The mixture was incubated at
37
 
8
 
C for 10 min to 3 h and then fixed for 10 min in 3.4% formal-
dehyde by adding 16 
 
m
 
l of 37% formaldehyde stock. Then the
mixture was washed twice in PBS containing 3.4% formaldehyde.
20 
 
m
 
l of anti-bleach was added to the cell pellet and the cells were
mounted on a glass slide and analyzed.
Image analysis was performed using a Zeiss Axiophot micro-
scope equipped with a cooled CCD camera CH250/a (Photo-
metrics Inc., Woburn, MA) with a KAF-1400-50 sensor chip
(1317 
 
3
 
 1035 pixels) driven by IPLabs Spectrum H-SU2 (version
3.0; Signal Analytics Corp., Vienna, VA) and Multiprobe 1.1 E
(Signal Analytics) software on a Power Macintosh 8100. The in-
tensity of the fluorescence was calculated using the above soft-
ware in which the x-axis represented a line starting outside the
cell (the background) then extending through the cytoplasm and
nucleus of the cell. The y-axis represents the relative fluorescence
intensity per pixel. All cell images were examined at the same
magnification and at the same light exposure time within a given
experiment. The value of intracellular fluorescence represents the
difference between the peak intracellular and the extracellular flu-
orescent intensity. Between 15 and 30 cells in a minimum of 5 ran-
domly chosen fields were analyzed for each experimental point.
 
Immunoelectronmicroscopy.
 
After incubation with GraB, cells
were fixed in suspension with an equal volume of 8% paraformal-
dehyde in 0.1 M PBS for 10 min at room temperature. Then cells
were centrifuged and resuspended in fresh paraformaldehyde for
1 h. The pelleted cells were cut into small blocks and placed into
a cryoprotectant mixture of 20% polyvinylpyrolidine, molecular
weight 10,000 (Sigma), and 1.84% sucrose for 4 h at room tem-
perature. The specimen was mounted and frozen in liquid nitro-
gen, then 75-nM sections were prepared on an RMC CR21 Cry-
osectioning system (EMLAB Equipment, Inc.,Whitby, Ontario).
Sections were mounted on a Formvar/carbon-coated grid, then
inverted and placed on droplets of mouse anti–human GraB (1/100
in 0.1% BSA in 0.1 M PBS) for 60 min at room temperature. The
grids were rinsed four times for 5 min in 0.1 M PBS and then
transferred to diluted 10 nM gold-labeled goat anti–mouse IgG
(Amersham Corp., Arlington Heights, IL) (1/10 in 0.1% BSA in
0.1 M PBS) for 30 min at room temperature. Grids were then
washed four times as above in 0.1 M PBS, then four more times
in distilled H
 
2
 
0. Sections were then protected by embedding in a
mixture of 20% polyvinyl alcohol, molecular weight 10,000
(Sigma), and 0.3% uranyl acetate (JB EM Services Inc., Montreal,
Quebec) for 10 min at room temperature for counterstaining sec-
tions. Then excess solution was wicked off with a filter paper.
Grids were dried and then examined with an electron microscope
(EM 400; Philips Technologies, Cheshire, CT).
 
Cell Microinjection.
 
Baxter glass cover slips 22 
 
3
 
 22 mm (Canlab) 
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were precleaned with chromic acid and preincubated with FCS
for 18 h at 37
 
8
 
C to prepare for tissue culture. The coverslips were
glued into a window cut from the base of a 60-mm Nunclon
petri dish with silicone sealant. B16 or Rat-1 cells were cultured
on the cover slips in 
 
a
 
-MEM and 10% FCS and allowed to ad-
here for several hours. Culture medium was then removed and
replaced with phenol red-free HBSS containing 20 mM Hepes and
2 mg/ml BSA. GraB was adjusted to 0.15 M NaCl in 20 mM so-
dium phosphate. Cells were microinjected manually with contin-
uous pressure of 20 hPa with an Eppendorf microinjector and
Femptotips (Eppendorf, Hamburg, Germany) or by automated
injection of a fixed volume using a Leitz micromanipulator (Leitz,
Wetzlar, Germany) on a heated stage. For image analysis, cells were
viewed through a Zeiss IM35 microscope and analyzed at 30-s
intervals by an Image-1 computer imaging system (Empix Imag-
ing, Mississauga, Ontario). In other experiments, 2 
 
m
 
l of 20 mM
Hoechst dye was added at various times after injection, and the cells
were examined 3–4 min later by fluorescent microscopy and pho-
tographed with a Contax 167MT camera with Tri-X pan 400 film.
Nuclear staining was rapid in cells after microinjection whereas
longer incubation periods were required in intact B16 cells (see
below).
In some experiments, cells were incubated on 22-mm round
glass coverslips, treated as above, in 24-well Nunclon plates for
24–48 h in 
 
a
 
-MEM and 10% FCS and then transferred to an-
other 24-well plate where they were incubated in 50 
 
m
 
l of HBSS
containing 20 mM Hepes, 1 mM EGTA, and 4 mM CaCl
 
2
 
. GraB
and perforin were diluted in 0.15 mM NaCl, 1 mM EGTA, and
20 mM Hepes to the appropriate concentration and then added
to the incubation medium for the indicated times at 37
 
8
 
C. The
coverslips were then incubated with 1 
 
m
 
l of 20 mM Hoechst
33258 dye for 1 h and inverted onto a Zeiss Axiovert 35M mi-
croscope slide for photomicroscopy.
 
Results
 
FITC-GraB Crosses the Plasma Membrane.
 
To determine
whether GraB entered cells, we examined the localization
of FITC-labeled human GraB using a high-sensitivity CCD
camera and image analysis to detect and quantify intracellu-
lar fluorescence. We first evaluated the apoptotic activity of
FITC-GraB to determine whether the fluorescenation of
the granzyme had ablated its biological activity. YAC-1
cells were incubated with increasing concentrations of
FITC-GraB (0.0625–2.0
 
 
 
m
 
g/ml) in the presence of a con-
stant amount of perforin (125 ng/ml). After 10 min of in-
cubation a low level of activity was detected on the basis of
Hoechst staining of apoptotic nuclei and by 30 min 
 
z
 
70%
of the cells had undergone apoptosis by the highest GraB
concentrations (Fig. 1 
 
A
 
, 
 
right
 
). The apoptosis produced by
FITC-GraB was equivalent to that induced by unlabeled
GraB and perforin (Fig. 1 
 
A
 
, 
 
left
 
).
We then determined if the FITC-GraB entered YAC-1
or HeLa cells after incubation with 1 
 
m
 
g/ml of the protease
for 10 or 30 min in the presence or absence of perforin
(Fig. 1 
 
B
 
). This dose of GraB produced 
 
z
 
50% apoptosis af-
ter 30 min in the presence of perforin (Fig. 1 
 
A
 
). Cells were
fixed and fluorescence distribution examined then quanti-
tated using a CCD camera with IPLabs Spectrum H-SU2
and Multiprobe 1.1 E (Signal Analytics) software (see Ma-
terials and Methods). Cells treated with FITC-GraB exhib-
ited an 8–12-fold increase in fluorescence within 10 min
with no further increase and perhaps a small decrease by 30
min of incubation (Fig. 1 
 
B
 
). Cells treated with both
FITC-GraB and perforin exhibited similar levels of intra-
cellular fluorescence compared with cells treated with FITC-
GraB alone at 10 min with a slight increase at 30 min (Fig.
1 
 
B
 
). Fig. 1, 
 
C–E
 
 illustrates the image analysis of intracellu-
lar fluorescence of two cells represented by peaks of fluo-
rescence after treatment with FITC-GraB (Fig. 1 
 
C
 
), with
FITC-GraB and perforin (Fig. 1 
 
D
 
), and the autofluores-
cence of untreated controls (Fig. 1 
 
E
 
).
Examination of the distribution of fluorescence in FITC-
GraB–treated cells, showed the most intense fluorescence
in the cytoplasm with a shadow evident over the nucleus
suggesting that the granzyme had not crossed the nuclear
membrane (Fig. 2, 
 
A
 
 and 
 
B
 
). However, in perforin- and
GraB-treated cells the fluorescence pattern had shifted dra-
matically. Here we observed that the nucleus of cells that
were undergoing apoptosis now stained strongly for FITC-
GraB (Fig. 2, 
 
B
 
 and 
 
C
 
). In HeLa cells, after 90 min of FITC-
GraB and perforin treatment, staining was evident around
the nuclear membrane with localized areas of fluorescence
in the nucleus (Fig. 2 
 
B
 
). In YAC-1 cells treated in the
same way, intense staining was evident in areas of chroma-
tin margination and in apoptotic bodies with fainter residual
staining in the cytoplasm (Fig. 2 
 
C
 
). To determine if pro-
teins other than FITC-GraB cross the nuclear membrane as
a result of apoptosis induced damage, we examined the fate
of rhodamine-conjugated transferrin administered to cells
with GraB and perforin. Under these conditions, transferrin
was excluded from the nucleus (Fig. 2 
 
D
 
). Cells were also
analyzed after treatment with different doses of FITC-GraB
ranging from 62.5 to 1,000 ng/ml in the presence or ab-
sence of perforin and showed the identical staining pattern
but with proportionately lower levels of fluorescence (not
shown).
To determine if the cell-associated GraB detected by flu-
orescence was sufficient to induce apoptosis, YAC-1 cells
were labeled with [
 
125
 
I]UdR then incubated with GraB (2
 
m
 
g/ml) for 15 min and then washed to remove extracellu-
lar protease. This was immediately followed by the addi-
tion of perforin at increasing concentrations. These cells
underwent apoptosis efficiently and in a dose-dependent
manner (Fig. 3 
 
A).
 
 If the cells were first treated with GraB
as above and then washed and incubated for increasing
times, the addition of perforin became gradually less effi-
cient at inducing DNA damage suggesting that the cell as-
sociated GraB had been progressively eliminated from the
cells (Fig. 3 
 
B
 
).
Next we determined whether GraB transit of the plasma
membrane was an active energy-dependent process. FITC-
GraB was incubated with cells that had been pretreated either
with NaF an inhibitor of glycolysis and DNP, which un-
couples oxidative phosphorylation, or incubated at 4
 
8
 
C.
Pretreatment with NaF and DNP in combination or incu-
bation at 4
 
8
 
C reduced fluorescence by 30–50% in either
YAC-1 or HeLa cells (not shown). When cells were treated 
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with both inhibitors at 4
 
8
 
C then fluorescence was reduced
by over 80% (Fig. 4 
 
A
 
). Cells examined under these condi-
tions revealed GraB in a patchy plasma membrane distribu-
tion, indicating that it had bound to but had not crossed
the cell membrane (Fig. 4 
 
B
 
). In earlier studies we had shown
that pretreatment of target cells with cytochalasin B, an in-
hibitor of actin polymerization and microfilament forma-
tion (29), blocked apoptosis induced by GraB and perforin
(7). When cytochalasin B was incubated with cells, we
found that the amount of FITC-GraB that entered the cell
was also profoundly suppressed (Fig. 4 
 
A
 
).
 
Detection of Cytoplasmic GraB by Immunoelectronmicroscopy.
 
To confirm the observation that GraB can enter cells in the
absence of perforin by an independent method, we next
Figure 1. Cytoplasmic uptake of FITC-GraB. (A, left) Apoptosis of
YAC-1 cells comparing GraB (filled triangles) to FITC-labeled GraB (filled
circles)with a constant amount of perforin (125 ng/ml). Apoptosis was
measured by the release of 125IUdR and the results are expressed as per-
centage of total label incorporated into the target cells. (Right) Apoptosis
of YAC-1 cells by increasing concentrations of FITC-GraB in the pres-
ence of perforin (125 ng/ml) incubated for 10 min (filled circles) or 30 min
(filled triangles) as indicated. Apoptosis was measured by the condensation
of chromatin visualized by Hoechst staining. (B) Quantitation of fluores-
cence label in YAC-1 cells treated with FITC-GraB (GraB) with or with-
out perforin (Perf). Cells were incubated in 1 mg/ml of FITC-GraB for 10
or 30 min then fixed and visualized with a CCD camera. Intracellular flu-
orescence was quantitated using an IPLabs Spectrum H-SU2 image analy-
sis program. At least 30 cells were measured for each condition and the
difference between extracellular and a maximum plateau of intracellular
fluorescence calculated and scored. Data is expressed as the mean and
SEM. The experiment was repeated several times with YAC-1 or HeLa
cells with the same result. (C) Fluorescence of two YAC-1 cells treated
for 30 min with FITC-GraB and analyzed using an IPLabs Spectrum image analysis program. Intracellular fluorescence was calculated for each cell by the
difference between the background surrounding the cell and the mean peak of intracellular fluorescence on the y-Axis. (D) Image analysis of two cells
treated with FITC-GraB and perforin for 30 min. (E) Image analysis of the autofluorescence of two YAC-1 cells used as background.859 Shi et al.
used colloidal gold labeling of GraB using anti-GraB anti-
body. YAC-1 cells were treated with 2 mg/ml of GraB and
then harvested and fixed at increasing time intervals of 10,
20, 45, and 60 min as described in Materials and Methods.
Ultrathin cryosections were prepared and then incubated
with anti-human GraB antibody or normal IgG control fol-
lowed by goat anti–mouse IgG colloidal gold (10 nM), and
then the cells were then examined by transmission electron
microscopy. Anti-GraB antibody colloidal gold staining was
found on the external surface of the plasma membrane as-
sociated with areas of increased electron density (Fig. 5 A).
Gold particles were also identified in the cell cytoplasm of
GraB-treated but not control cells treated with primary and
secondary antibody but without GraB preincubation (Fig. 5,
B–D). Colloidal gold was not seen associated with any par-
ticular cellular structure but was distributed throughout the
cytoplasm and was sometimes observed near the nuclear en-
velope as illustrated in Fig. 5, B and C. No gold particles
Figure 2. (A) Intracellular fluorescence of cells treated with FITC-
GraB in the presence and absence of perforin. HeLa cells are shown 30
min after incubation with FITC-GraB (1 mg/ml). The fluorescence is dis-
tributed diffusely throughout the cytoplasm and a shadow indicating
lower levels is seen over the nucleus. After treatment with FITC-GraB
and perforin for 30 min both HeLa cells (B) or YAC-1 cells (C) showed a
dramatic redistribution with the FITC-GraB now seen in the nucleus
with some cytoplasmic staining. In HeLa cells (B) the fluorescence was
distributed around the nuclear membrane and in localized areas in the nu-
cleus while in YAC-1 cells (C) the fluorescence was detected in areas of
condensed chromatin or in apoptotic bodies. YAC-1 cells were treated
with GraB and perforin in the presence of rhodamine-conjugated trans-
ferrin (D). Transferrin was not detected in the nucleus in cells undergoing
apoptosis (arrow). Cells from GraB and perforin treatment in the presence
of rhodamine-conjugated transferrin shown in D were stained with Hoechst
dye to demonstrate the condensed chromatin in the apoptotic nucleus
(E). The experiments described above were repeated at least three times
with each target cell.860 Granzyme B Target Cell Entry and Apoptosis
were detected in the nucleus. At later time points the
amount of GraB in the cell cytoplasm was either equiva-
lent to the 15-min time point or somewhat decreased. The
nucleus of the cells and the overall cell morphology was
not significantly altered (Fig. 5 C).
GraB Microinjection into the Cytoplasm. It was evident
from the above experiments that GraB crossed the cell
membrane and was found within the cytoplasm in the ab-
sence of perforin but produced no obvious damage to the
cells. If GraB can enter the target cell but fails to initiate apop-
tosis then it is possible that it is unable to enter the cell in
sufficient quantity on its own to cleave and activate its sub-
strates. Another possibility is that GraB is in some way seg-
regated from the substrates that it uses to initiate apoptosis.
To test these hypotheses, we directly microinjected GraB
into the cell cytoplasm. B16 melanoma cells, which are
highly susceptible to GraB and perforin-induced apoptosis
within 2 h, were injected with either GraB (2 mg/ml) or
buffer control and observed by DIC microscopy using an
Image 1 time lapse image analysis system over a 2–3-h pe-
riod. We observed changes to both the nucleus and plasma
membrane within a few minutes of placing the protease in
the cytoplasm. In 4–6 min the nuclear membrane and nu-
cleolus appeared coarse and more prominent compared to
control injections (Fig. 6, A and B). The plasma membrane
began blebbing starting z5–7 min after injection which
became pronounced by 8–12 min. However, in no in-
stance did we observe progression to obvious membrane or
nuclear disruption. Membrane blebs were usually transient
in that they appeared and disappeared quickly. Nuclear
changes also did not progress over the observation period.
The rate at which the blebbing and nuclear changes oc-
curred was dependent on the concentration of the GraB in
the injection buffer. At high concentrations the changes
were evident by 4–12 min, while at lower concentrations
the effects were delayed to 20 min or longer. The experi-
ment was repeated using the Rat-1 cell, microinjecting
GraB at a 10-fold high concentration (20 mg/ml) using an
automated injection protocol in which 1.2 3 10212 ml was
injected per cell containing 0.2–0.4 femtograms. Cells were
again followed for 2–3 h and no apoptosis was observed.
To more directly visualize whether nuclear apoptotic
changes occurred in microinjected cells we used Hoechst
33258 dye. The cytoplasm of B16 melanoma cells (Fig. 6 C)
was microinjected with GraB and then stained at different
time intervals with Hoechst dye. The cells exhibited nu-
Figure 3. Cell associated GraB induces apoptosis with the addition of
perforin. (A) 125IUdR-labelled YAC-1 cells were preincubated in GraB
(2 mg/ml) for 15 min, then washed and perforin added at increasing con-
centrations and the percent apoptotic cells calculated after incubation for
3 h. (B) GraB (2 mg/ml) was incubated with YAC-1 cells for 15 min,
washed, and then incubated for increasing periods of time as shown. Cells
were then washed again and perforin added for an additional 3 h. (Filled
circles) 60 ng/ml, (filled squares) 30 ng/ml, (filled triangles) 15 ng/ml. 
Figure 4. GraB crosses the plasma membrane by an energy-dependent
mechanism. (A) HeLa cells were treated with NaF (1 mM) an inhibitor of
glycolysis and DNP (100 mM) which uncouples oxidative phosphoryla-
tion at 48C or cytochalasin B (Cytoch B) (2 mg/ml) and then incubated
with FITC-GraB (GraB) or GraB and perforin (Perf) for 30 min then ana-
lyzed as described in Fig. 2. (B) Cells treated with DNP/NaF at 48C then
FITC GraB showed fluorescence localized to the plasma membrane in
discreet patches or clumps.861 Shi et al.
clear changes that were mainly characterized by prominent
nucleoli or localized areas of chromatin condensation but
they did not display the intense chromatin condensation ob-
served in cells incubated with GraB and perforin (Fig. 6 D).
Control B16 cells (Fig. 6 E) or those treated with either
perforin or GraB alone (not shown) were unchanged and
stained in a diffuse punctate pattern.
A second method of determining if cytoplasmic intro-
duction of GraB was sufficient to induce apoptosis was to
solubilize the plasma membrane with the detergents digito-
nin or Triton X-100 to allow free entry of the granzyme
into the cell. We determined if the detergents over a wide
concentration range could support GraB induced apoptosis
of YAC-1 cells. At none of the doses of either detergent
were we able to see evidence of DNA damage measured by
125IUdR release compared to perforin in the same experi-
ment (Fig. 7, A and B).
Discussion
In the granule exocytosis model of killing it was pro-
posed that after contact between the CTL and target cell,
perforin and granzymes are released into the intercellular
space (30). Perforin then assembles into a pore-like struc-
ture in the target cell plasma membrane under the influ-
ence of calcium (30, 31), however, the fate of the released
Figure 5. Detection of intracellular GraB by immunogold staining. YAC-1 cells incubated in GraB (2 mg/ml) for 10 min were washed and fixed, then
thin cryosections incubated with murine anti-GraB antibody or colloidal gold goat anti–mouse IgG. (A) Colloidal gold anti-GraB (arrows) localized to an
area of increased electron density on the external leaf of the plasma membrane. (B) High power magnification of gold particles (arrows) in the cytoplasm
near the nuclear membrane. (C) A lower magnification of B showing the position of the immunogold in the whole cell (arrows). (D) YAC-1 cell treated
with anti-GraB antibody and immunogold in the absence of GraB had no detectable gold particles.862 Granzyme B Target Cell Entry and Apoptosis
granzymes is not known. CTL and NK cells of mice defi-
cient in GraB are unable to fully induce apoptosis (9), and
GraB apoptotic activity can be blocked by the tripeptide
inhibitor Boc-Ala-Ala-Asp-cmk pretreatment (6), indicat-
ing that a proteolytic active GraB is required for apoptosis.
The cleavage and activation of one or more members of
the ICE family proteases has been proposed as a mechanism
for initiation of GraB action (16–23). At least two possibili-
ties can be considered that would allow GraB to activate
these intracellular cysteine proteases after being released by
CTL at the external face of the target cell membrane. The
granzyme hydrolyses a cell surface protein that triggers the
activation of ICE family proteases through a second mes-
senger similar to the model proposed for Fas/TNF-R1 ac-
tivation (21, 22), or GraB crosses the plasma membrane to
initiate the activation by direct proteolysis of ICE family
proteases (16–23). In this study we have shown that GraB is
capable of crossing the plasma membrane and entering the
target cell and it does this in the absence of perforin. However,
it is only in the presence of perforin that apoptosis is induced
and GraB is then also found in the target cell nucleus.
GraB may first attach to the cell surface and then be
translocated across the plasma membrane into the cytoplasm.
We detected GraB on the cell membrane by immunogold
Figure 6. Microinjection of GraB into the cytoplasm of B16 mela-
noma. After GraB (2 mg/ml) (A) or medium (B) injection into B16 cells
(injected cells indicated by arrows), the B16 cells were examined by DIC
microscopy using image analysis. After 6 min the cell nucleoli became
prominent and by 12 min plasma membrane blebbing was noted (arrow-
heads). No further changes were observed over the next 60 min. Plasma
membrane and nuclear changes were transient. (C) Hoechst dye staining
of GraB microinjected B16 melanoma cells. A group of cells were in-
jected with GraB (1 mg/ml) and after 45 min stained with Hoechst dye.
Similar to the DIC microscopy (Fig. 3) the only nuclear changes observed
was the increasing prominence of the nucleoli (arrows). Microinjection
experiments were repeated at different doses and times in at least five sep-
arate experiments. (D) Cells incubated in GraB (1 mg/ml) and perforin
(60 ng/ml) for 45 min display the typical chromatin condensation pattern
of apoptotic cells (arrows). (E) Control cells incubated in medium.863 Shi et al.
staining with anti-GraB antibody and by direct fluores-
cence of FITC-GraB in cells in which membrane activity
was blocked. How the GraB attaches to the plasma mem-
brane is not known. Although it is possible that there is a
receptor for GraB, its highly cationic nature suggests that
this may be nonspecific perhaps similar to its interaction
with chondroitin sulfate proteoglycan in the granule matrix
(32). Once bound, movement across the membrane ap-
pears to be energy dependent as the addition of NaF and
DNP and the maintenance of low temperature prevents ac-
cumulation of FITC-GraB in the cytoplasm.
Once in the cytoplasm, there were no cellular structures
identified with which GraB was associated. FITC-GraB
stained the cytoplasm diffusely. Although some immu-
nogold staining was detected along the nuclear membrane
and a some gold particles were found within and along the
edges of micropinocytic vesicles, most gold staining was
not associated with any structure in the cytoplasm. In the
absence of perforin, GraB appears to be excluded from the
nucleus at least at the limits of our detection systems with
either the localization of FITC-GraB or colloidal gold anti-
GraB antibody staining. This contrasts with earlier observa-
tions that GraB is taken up by isolated nuclei from YAC-1
cells (27). In this isolated nucleus model, GraB crosses the
nuclear membrane by an energy-independent nuclear im-
port mechanism that may use a cytoplasmic transport fac-
tor. The uptake exhibits some specificity as another serine
protease, chymotrypsin, is not imported to the nucleus un-
der the same conditions. One might reconcile the observa-
tion that intact cell nuclei do not take up GraB proposing
that the nuclear transport mechanism has been abnormally
activated in isolated nuclei, and that it remains inactive in
intact cells. However, further work on the nature of the
nuclear transport mechanism will be needed to resolve this
issue. In addition, other experiments indicate that isolated
nuclei do not undergo chromatin condensation and DNA
fragmentation with GraB in the absence of cytosol and that
an ICE family substrate must be cleaved before nuclear apop-
tosis is initiated (24). These experiments support a model in
which GraB initiates apoptosis by a cytoplasmic ICE family
protease signal that leads to nuclear changes. However, it
appears that GraB is unable to initiate nuclear apoptotic
changes in the absence of perforin signaling.
Data from this current study demonstrate that the auton-
omous entry of GraB into the cytoplasm or its direct mi-
croinjection does not initiate apoptosis until perforin is de-
livered to the cell. Although the current model of initiation
of a cytoplasmic apoptotic signal by GraB is the cleavage
and activation of ICE family proteases, the presence of the
active GraB protease in the cell cytoplasm appears to be in-
sufficient to cleave ICE proteases. We have shown that in-
cubation of GraB with YAC-1 or HeLa cells in the absence
of perforin for 2 h or more does not result in the hydrolysis
of either p45 ICE or CPP32 and its substrate poly-ADP ri-
bose polymerase (PARP) (25). In the presence of perforin
the same dose of GraB induces cleavage and activation of
both ICE proteases and the hydrolysis of PARP to p85
within 45 min (25). The simplest explanation of why the
GraB that autonomously enters the cell does not cleave ICE
proteases is that an insufficient amount has entered the cell
in the absence of perforin. Although we cannot detect an
increase in the cytoplasmic levels by our methods, perforin
may rapidly move GraB from the cell membrane to the nu-
cleus and a transient rise sufficient for apoptosis may have
occurred. Similarly, we may not have been able to micro-
inject sufficient GraB to activate cell death. The level of
cytoplasmic GraB that must be reached to activate apopto-
sis is not known, so we can conclude that the amount we
microinject (4 femtograms per cell) is not sufficient.
We have considered several other possible explanations
for why cytoplasmic GraB does not initiate CPP32 or ICE
cleavage and apoptosis in the absence of perforin: (a) ICE
family proteases are sequestered and not available to GraB,
(b) ICE proteases are not the primary target of GraB, (c)
GraB is not active without further posttranslational process-
ing, or (d) GraB is blocked or suppressed. Although ICE is
found as a cytoplasmic protein in monocytes (33), the pre-
cise intracellular localization of ICE family proteases in
other cell types has not been determined. CPP32 can cleave
nuclear substrates including the DNA repair enzymes PARP
and DNA-PK early in apoptosis (34). Thus, CPP32 most
probably enters the nucleus during apoptosis to access these
Figure 7. GraB is inactive
against YAC-1 target cells with
detergent permeabilized plasma
membrane. (A) GraB was titered
against a constant dose of per-
forin (40 ng/ml). (Filled triangles)
Increasing amounts of Triton
X-100 were added to cells with
either a constant dose of GraB
(1 mg/ml) (filled circles) or me-
dium control (filled squares). (B)
GraB titered with perforin as in
Fig. 1 A (filled triangles). GraB
(1 mg/ml) was incubated with
increasing amounts of digitonin
(filled circles) and compared to in-
cubation with digitonin only
(filled squares).864 Granzyme B Target Cell Entry and Apoptosis
substrates. It is possible that GraB may cleave ICE proteases
such as CPP32 in the nucleus after their movement across
the nuclear membrane. However, since granzyme can in-
duce apoptotic membrane and cytoplasmic changes in the
absence of a nucleus (35), the ICE family protease process-
ing almost certainly can take place in the cytoplasm. Another
possibility is that the internalized GraB may be sequestered
within vesicles after transport across the plasma membrane.
However, we do not see any evidence of this by electron-
microscopy and the cytoplasmic distribution of FITC-GraB is
quite diffuse. Thus, we can find no evidence to support the
physical sequestration of this granzyme. However, the pos-
sibility remains that GraB may enter the cell in a microvesicle
then rapidly translocates to the cytoplasm making it difficult
to detect within a vesicle by the methods we have employed.
The second possibility, that ICE proteases in the cyto-
plasm are not the primary target of GraB, would be surpris-
ing since there are so many ICE family proteases that can
be activated by GraB processing (16–23). However, GraB
may hydrolyze another protein that initiates the activation
of many different ICE family proteases. The availability of
this substrate would also have to be restricted in some way
in the absence of perforin.
The third possibility is that GraB must be further post-
translationally processed. The protease does exist in several
glycosylated forms which have unknown function but are
not accessible to the nucleus (27), thus, deglycosylation may
be necessary for activity. The precursor of GraB is pro-
cessed by a dipeptidyl peptidase I and remains inactive until
the removal of an NH2-terminal dipeptide (36). The GraB
preparations used in our study are quite active against syn-
thetic peptide substrates and do not require any further pro-
cessing. However, we cannot rule out other types of intra-
cellular processing that are required for GraB apoptotic
activity.
The last possibility is that GraB activity is blocked or
suppressed until perforin releases this inhibition. In that re-
gard, we found that the microinjection of GraB had an
identifiable although transient effect on the cell (Fig. 6, A
and B). The changes that were seen were similar to the
early stages of apoptosis with plasma membrane blebbing
and nuclear coarsening even though they did not proceed
to intense chromatin condensation. This inability to pro-
gress to apoptosis might be explained by the inactivation or
inhibition of GraB after injection. Consistent with this idea
was the observation that cells that were pretreated with GraB
and washed became progressively less able to induce apop-
tosis with time before perforin addition (Fig. 3 B), again
suggesting inactivation. The existence of molecules that in-
hibit GraB is limited to the cowpox serine protease inhibi-
tor crmA (37), and no equivalent molecule has been identi-
fied in eukaryotic cells. It is not known whether other
inhibitors of apoptosis exist in mammalian cells that are ac-
tive against GraB.
Although a great deal is known about the structure of
perforin and its requirement for CTL and NK activity, its
function at the cellular level remains obscure. The hypoth-
esis that it acts as a membrane channel to allow granzymes
to cross the cell membrane is not supported by the experi-
ments presented in this paper. GraB enters cells without
perforin, and the addition of perforin had little effect on
cytoplasmic levels of GraB in YAC-1 or HeLa cells. It is es-
timated that up to 20 perforin monomers form a functional
pore, which is a transmembrane tubular structure (10, 38–43).
Studies in artificial bilayer membranes and resealed erythro-
cyte ghosts indicate that the functional pore radius is 3.1–6
nm. Pores have been shown to allow the movement of var-
ious monovalent and divalent ions regardless of charge and
small molecules such as glucosamine with a Stokes diameter
of 8 Å (40, 41, 43). Perforin pores formed by granules from
cytotoxic lymphocytes allow the release of an 8,000 dalton
polypeptide a-bungerotoxin (41). To this point, no one
has directly shown that a molecule the size of GraB, which is
32 kD, is able to move through a perforin pore, and the
data from this study argues that a perforin pore is not re-
quired for it to cross the plasma membrane.
Although perforin has little effect on the level of GraB
we detect in the cell, it resulted in dramatic localization of
the protease to the nucleus. It is not clear from these exper-
iments whether nuclear localization is a consequence or
cause of apoptotic changes in the nucleus. The exact role of
perforin in apoptosis induction by GraB is also obscure. As
noted above, perforin can promote Ca21 influx into cells.
One possibility is that a perforin-induced increase in intra-
cellular calcium triggers the activity of GraB or proteins that
are hydrolyzed by GraB (10–12). We attempted to answer
this question by replacing perforin with ionomycin, a cal-
cium ionophore, either when GraB is applied to the exter-
nal cell surface of intact cells or microinjected, but we were
not able to reproduce the effect of perforin (L. Shi and
A.H. Greenberg, unpublished data). Another possibility is
that perforin initiates a signal from the cell membrane, such
as the release of a second messenger, and this molecule is
critical to activating GraB-induced apoptosis. At the mo-
ment, there is no data to support or refute this hypothesis,
so it remains only a speculative possibility. However, un-
derstanding the role of perforin in triggering GraB activity
may have direct relevance to the regulation of other initia-
tors of apoptosis.
In conclusion, we have demonstrated that GraB can au-
tonomously enter the cytoplasm of target cells where it re-
mains until perforin initiates apoptosis and its translocation
to the nucleus.
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